Selected Publications
-
article
- Objective Performance Status: Enhancing Cancer Patient Fitness Assessment With Wearable Technology.. JCO oncology practice. -. 2025
- The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis.. British journal of haematology. 207:860-868. 2025
- Community oncologists' perspectives on hospice and palliative care for older adults with acute myeloid leukemia: A qualitative study.. Journal of geriatric oncology. 16:-. 2025
- Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study.. American journal of hematology. 100:1678-1681. 2025
- Connecting the Dots: Practical Strategies for Academic and Community Oncology Synergy to Advance Multidisciplinary Management in Immunotherapy Toxicity Care.. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 45:-. 2025
- Navigating Challenges in Palliative Care: A Survey on ASCO Guideline Adherence Among Health Care Providers in Low- and Middle-Income Countries.. JCO global oncology. -. 2025
- Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma.. Blood advances. 9:1117-1131. 2025
- Challenges of treating mantle cell lymphoma in older adults.. Leukemia & lymphoma. 66:433-450. 2024
- Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.. Leukemia. 39:503-507. 2024
- Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being Undetectable.. Current oncology reports. 26:1664-1674. 2024
- Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism.. Journal of thrombosis and haemostasis : JTH. 23:149-157. 2024
- Measurable Residual Disease and Clinical Outcomes in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis.. JAMA oncology. 10:1221-1227. 2024
- Transformative Peer Connections: Early Experiences From the ASCO Palliative Care Community of Practice.. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 44:-. 2024
- Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.. Blood advances. 8:2085-2093. 2024
- Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report.. Journal of geriatric oncology. 15:-. 2024
- Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.. JCO oncology practice. 20:739-741. 2024
- Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.. The oncologist. 29:e351-e359. 2024
- Geriatric Assessments in Older Adults With Cancer.. JAMA oncology. 9:-. 2023
- Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms.. Leukemia & lymphoma. 64:2347-2350. 2023
- "Celebrating Resilience": A review of abstracts on functional resilience at the International Society of Geriatric Oncology 2022 annual meeting.. Journal of geriatric oncology. 14:-. 2023
- Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.. Blood advances. 7:3146-3149. 2023
- Where the Sidewalk Ends: Parenting as a Trainee during COVID-19.. Cancer investigation. 41:559-567. 2023
- Professional Challenges for United States Hematology/Oncology Trainees during COVID-19.. Cancer investigation. 41:539-547. 2023
- Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.. American journal of hematology. 98:900-912. 2023
- EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.. Leukemia & lymphoma. 64:1026-1034. 2023
- The epidemiology of preexisting geriatric and palliative conditions in older adults with poor prognosis cancers.. Journal of the American Geriatrics Society. 70:3402-3412. 2022
- Older patients' experiences following initial diagnosis of acute myeloid leukemia: A qualitative study.. Journal of geriatric oncology. 13:1230-1235. 2022
- Geriatric assessment in older adults with Non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper.. Journal of geriatric oncology. 13:572-581. 2022
- Decision-making about clinical trial options among older patients with metastatic cancer who have exhausted standard therapies.. Journal of geriatric oncology. 13:594-599. 2022
- Key recommendations from the 2021 "inclusion of older adults in clinical research" workshop.. Journal of clinical and translational science. 6:-. 2022
- Tumor metabolism and neurocognition in CNS lymphoma.. Neuro-oncology. 23:1668-1679. 2021
- Primary central nervous system lymphoma in older adults and the rationale for maintenance strategies: a narrative review.. Annals of lymphoma. 2021
- Decisional involvement and information preferences of patients with hematologic malignancies.. Blood advances. 4:5492-5500. 2020
- On point in primary CNS lymphoma.. Hematological oncology. 38:640-647. 2020
- Geriatric hematology research at the 2019 American Society of Hematology annual meeting: Young International Society of geriatric oncology perspective paper.. Journal of geriatric oncology. 11:735-739. 2020
- 79-Year-Old Woman With Jaundice and Anemia.. Mayo Clinic proceedings. 93:381-385. 2017
- A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.. Current hematologic malignancy reports. 12:29-38. 2017
- Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis.. Blood. 127:1752-60. 2016
- The efficacy of ibrutinib in the treatment of Richter syndrome.. Blood. 125:1676-8. 2015
- The importance of empathy--as I have studied and experienced it.. Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health. 72:79-80. 2013
- Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 27:1153-66. 2012